What we do
We conduct pioneering research into stem cell transplant treatments, looking for new ways to increase their effectiveness.
Across the cell and gene therapy industry, the number of allogenic cell-based therapies in development is greater than ever, but unlike in some other areas of ground-breaking clinical work, the starting materials required cannot simply be manufactured.
Anthony Nolan’s Cell and Gene Therapy Services were launched to help meet demand for quality donor products, with the aim of helping our partners save and improve the lives of millions of people.
Our expertise
Anthony Nolan has been sourcing and transporting cellular material from donor to patient since 1974. Today, we replicate that journey to bring cells from donor to researcher.
Our stem cell register gives us access to 900,000+ potential donors and our cord blood bank contains over 10,000 clinical grade units.
Our Cell Therapy Centre has the facilities to manage the processing, characterisation and delivery of large quantities of quality cellular products, and is fully compliant with regulatory requirements. All materials are ethically-sourced and fully consented.
If you’re unsure about which products you need, our business development team can help guide you to the most appropriate starting material for your research project. Contact us now, and we’ll aim to get back to you within one working day.
Working in partnership
Anthony Nolan is UK-based with a global reach through our trusted network of partners - including apheresis centres around the country, and universities, pharma and biotech companies across Europe.
Our partners come to us again and again to procure high quality cellular products, adult donor and/or umbilical cord material, to the specifications and standards that they expect.
Whether you’re working on an early-stage concept, clinical trial or a project that’s further down the pipeline, Contact us today and you’ll see why so many of our clients become long-term partners.